Filter
577
Filtered Results: 577
Text search:
Guide
to
good
manufaturing
Practice
Featured
Recommendations
61
New Publications
153
Language
Document type
No document type
283
Studies & Reports
106
Guidelines
97
Manuals
37
Strategic & Response Plan
35
Fact sheets
7
Training Material
6
Situation Updates
4
Brochures
1
Resource Platforms
1
Countries / Regions
India
32
Kenya
20
Uganda
16
Ghana
15
Nigeria
15
Global
14
Ethiopia
14
South Africa
12
Sierra Leone
10
Rwanda
10
Nepal
9
Africa
9
Western and Central Europe
9
Liberia
9
Philippines
8
Namibia
8
Tanzania
7
Ukraine
6
Zimbabwe
6
Bangladesh
6
Botswana
6
Zambia
6
Lesotho
5
South–East Asia Region
5
Malawi
4
Guinea
4
Haiti
4
Latin America and the Carribbean
4
West and Central Africa
4
Thailand
3
Asia
3
Congo, Democratic Republic of
3
East and Southern Africa
3
Eastern Europe
3
Myanmar / Burma
3
Eswatini/ Swaziland
3
Cameroon
2
Syria
2
Albania
2
Laos
2
USA
2
Cambodia
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Moldova
2
South Sudan
2
Indonesia
2
Tajikistan
1
Turkey
1
Australia
1
Benin
1
China
1
Burkina Faso
1
Mozambique
1
Germany
1
Middle East and North Africa
1
Turkmenistan
1
Maldives
1
Mauritius
1
United Kingdom
1
Bosnia and Herzegovina
1
Russia
1
Sudan
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
217
Clinical Guidelines
43
Key Resources
35
Public Health
32
Pharmacy & Technologies
27
Women & Child Health
15
Capacity Building
6
Toolboxes
Pharmacy
65
AMR
48
COVID-19
43
HIV
28
Planetary Health
28
TB
23
Rapid Response
17
NTDs
17
Mental Health
13
Disability
13
Ebola & Marburg
13
Specific Hazards
11
Conflict
11
Natural Hazards
10
NCDs
9
Health Financing Toolbox
8
Global Health Education
8
Refugee
6
Caregiver
5
Cholera
3
Malaria
1
Zika
1
Polio
1
Introduction
Capter A.1
Ethics and international child and adolescent psychiatry
This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level of households, and access to and use of medicines for acute and chronic conditions as well as opinions and perceptio...
Policy Brief
Accessed: 20.11.2019
WBCSD Vision 2050 sets out the goal to achieve the highest attainable standard of health and wellbeing for everyone by 2050, calling for a world in which: people live healthy lives; societies promote and protect health; everyone has access to robust, resilient and sustainable healthcare services; an...
Antibiotics use with care
More than two years since the first SARS-CoV-2 infections were reported, the COVID-19 pandemic remains an acute global emergency. In this Strategic Preparedness, Readiness and Response plan for 2022, WHO sets out a number of key strategic adjustments that, if implemented rapidly and consistently at ...
The seventh WHO Report on the global tobacco epidemic analyses national efforts to implement the most effective measures from the WHO Framework Convention on Tobacco Control (WHO FCTC) that are proven to reduce demand for tobacco.
The report showed that while only 23 countries have implemented ce...
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
A Guide For Multicentre Trials in High-Burden Countries
This training module is designed to equip HWs with knowledge and communication skills to build their confidence and support them in their ability to promote acceptance of COVID-19 vaccination among other HWs.
Responses to epidemics, emergencies and disasters raise many ethical issues for the people involved, including public health specialists and policy makers. This training manual provides material on ethical issues in research, surveillance and patient care in these difficult contexts.
High prices, hard-to-access human insulin, few insulin producers, and weak health systems are just some of the barriers that people with diabetes face a century after insulin was discovered, WHO notes in a new report
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
Access to controlled medicines. 3rd edition
